116 related articles for article (PubMed ID: 8585398)
1. Relationship between body mass index (BMI) and changes in plasma total and HDL-cholesterol levels during treatment of hypertension in African patients.
Ahaneku JE; Agbedana OE; Taylor OG
Acta Med Okayama; 1995 Oct; 49(5):267-70. PubMed ID: 8585398
[TBL] [Abstract][Full Text] [Related]
2. Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
Ahaneku JE; Taylor GO; Agbedana EO; Walker O; Salako LA
J Pak Med Assoc; 1994 Jul; 44(7):166-9. PubMed ID: 7933456
[TBL] [Abstract][Full Text] [Related]
3. Effects of doxazosin and hydrochlorothiazide on lipid levels in Korean patients with essential hypertension.
Jones DW; Sands CD
J Cardiovasc Pharmacol; 1993 Sep; 22(3):431-7. PubMed ID: 7504134
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure and blood glucose levels during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
Ahaneku JE
Kobe J Med Sci; 1996 Feb; 42(1):19-29. PubMed ID: 8984227
[TBL] [Abstract][Full Text] [Related]
5. Biochemical changes during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
Ahaneku JE; Taylor GO; Walker O; Agbedana EO; Sowunmi A; Salako LA
J Pak Med Assoc; 1996 Apr; 46(4):71-3. PubMed ID: 8991356
[TBL] [Abstract][Full Text] [Related]
6. Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
Fogari R; Zoppi A; Malamani GD; Marasi G; Vanasia A; Villa G
Br J Clin Pharmacol; 1995 May; 39(5):471-6. PubMed ID: 7669481
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.
Grimm RH; Flack JM; Grandits GA; Elmer PJ; Neaton JD; Cutler JA; Lewis C; McDonald R; Schoenberger J; Stamler J
JAMA; 1996 May 22-29; 275(20):1549-56. PubMed ID: 8622245
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
Trost BN; Weidmann P; Riesen W; Claessens J; Streulens Y; Nelemans F
Am J Cardiol; 1987 May; 59(14):99G-104G. PubMed ID: 2884861
[TBL] [Abstract][Full Text] [Related]
9. Influence of baseline values. II: Variations in plasma lipoprotein fractions during doxazosin treatment for hypertension.
Ahaneku JE; Taylor GO; Agbedana EO
Int J Clin Pharmacol Res; 1998; 18(4):165-70. PubMed ID: 10052026
[TBL] [Abstract][Full Text] [Related]
10. Influence of baseline values. I: Effects on plasma total cholesterol and triglyceride levels during doxazosin treatment for hypertension.
Ahaneku JE; Taylor GO; Agbedana EO; Walker O; Salako LA
Int J Clin Pharmacol Res; 1998; 18(4):159-63. PubMed ID: 10052025
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive and metabolic effects of Angiotensin receptor blocker/diuretic combination therapy in obese, hypertensive African American and white patients.
Ofili EO; Zappe DH; Purkayastha D; Samuel R; Sowers JR
Am J Ther; 2013 Jan; 20(1):2-12. PubMed ID: 22248871
[TBL] [Abstract][Full Text] [Related]
12. Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension. The Alpha Beta Canada Trial Group.
Carruthers G; Dessain P; Fodor G; Newman C; Palmer W; Sim D
Am J Cardiol; 1993 Mar; 71(7):575-81. PubMed ID: 8438744
[TBL] [Abstract][Full Text] [Related]
13. Open trial of doxazosin in hypertensive Africans: dose finding, efficacy and safety studies.
Sowunmi A; Salako LA; Walker O
Afr J Med Med Sci; 1996 Mar; 25(1):53-9. PubMed ID: 9110055
[TBL] [Abstract][Full Text] [Related]
14. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.
Weber MA; Jamerson K; Bakris GL; Weir MR; Zappe D; Zhang Y; Dahlof B; Velazquez EJ; Pitt B
Lancet; 2013 Feb; 381(9866):537-45. PubMed ID: 23219284
[TBL] [Abstract][Full Text] [Related]
15. Doxazosin, but not amlodipine decreases insulin resistance in patients with chronic renal failure: a prospective, randomized-controlled study.
Yildiz A; Hursit M; Celik AV; Kayacan SM; Yazici H; Akkaya V; Gürol AO; Karsidag K
Clin Nephrol; 2002 Dec; 58(6):405-10. PubMed ID: 12508961
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension.
Ram CV; Ames RP; Applegate WB; Burris JF; Davidov ME; Mroczek WJ
Clin Cardiol; 1994 May; 17(5):251-6. PubMed ID: 8004839
[TBL] [Abstract][Full Text] [Related]
17. Clinically additive effect between doxazosin and amlodipine in the treatment of essential hypertension.
Nalbantgil S; Nalbantgil I; Onder R
Am J Hypertens; 2000 Aug; 13(8):921-6. PubMed ID: 10950401
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of initiating therapy with amlodipine and hydrochlorothiazide or their combination in hypertensive Nigerians.
Iyalomhe GB; Omogbai EK; Isah AO; Iyalomhe OO; Dada FL; Iyalomhe SI
Clin Exp Hypertens; 2013; 35(8):620-7. PubMed ID: 23510493
[TBL] [Abstract][Full Text] [Related]
19. Principal results of the Hypertension and Lipid Trial (HALT): a multicenter study of doxazosin in patients with hypertension.
Levy D; Walmsley P; Levenstein M
Am Heart J; 1996 May; 131(5):966-73. PubMed ID: 8615318
[TBL] [Abstract][Full Text] [Related]
20. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
Lehtonen A; Himanen P; Saraste M; Niittymäki K; Marniemi J
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
